Salix Pharmaceuticals Ltd. (SLXP) Stock Quote

Detailed Quote for Salix Pharmaceuticals Ltd. (SLXP) 
$ 39.4995   0.3995 (+1.02%) Volume: 47.21 k 10:31 AM EDT Sep 2, 2010
Today 5d 1m 3m 1y more
Last Price
39.4995
Change $
0.3995
Change %
1.02%
Tick
  
Bid
39.47
Bid Size
100
Ask
39.50
Ask Size
300
Open
39.06
High
39.56
Low
38.98
Prev Close
39.10
Last Trade
10:31
Volume
47.21 k
52 Wk Hi
45.00
52 Wk Low
11.96
Market Cap
2.28 b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
57,816,021
EPS (TTM)
-1.13
PE Ratio
N/A
Exchange
NGS
News and Media for Salix Pharmaceuticals Ltd.  (SLXP) 
Sector News | Topic News
News for SLXP
Mon, Aug 30, 2010
2:15 PM Salix Pharmaceuticals Announces Settlement of Pending Litigation Regarding MOVIPREP(R) - Business Wire
Mon, Aug 09, 2010
4:01 PM Salix Pharmaceuticals Reports 2Q2010 Results - Business Wire
9:58 AM Salix Announces FDA Acceptance for Filing and Priority Review Designation For XIFAXAN550 sNDA For the Treatment of Non-Constipation Irritable Bowel Syndrome - Business Wire
Thu, Aug 05, 2010
7:00 AM Salix Pharmaceuticals to Present at Bank of America Merrill Lynch Conference - Business Wire
Thu, Jul 29, 2010
7:00 AM Salix Pharmaceuticals to Present at BMO Capital Markets Conference - Business Wire
Mon, Jul 26, 2010
7:00 AM Salix Pharmaceuticals Announces 2Q2010 Financial Results Conference Call and Webcast - Business Wire
Wed, Jun 16, 2010
7:00 AM Salix Pharmaceuticals to Present At NASDAQ Conference - Business Wire
Tue, Jun 08, 2010
7:01 AM Salix Pharmaceuticals Announces NDA Submission For XIFAXAN550 For Treatment of Non-Constipation Irritable Bowel Syndrome - Business Wire
Thu, Mar 25, 2010
7:55 AM FDA approves Xifaxan for liver disease - United Press International
Mon, Nov 23, 2009
6:25 AM The Fortune Financial Coverage of New Alliance Bancshares Inc., Men's Wearhouse Inc., Microsoft Corp., Hercules Offshore Inc., News Corp. and Salix Pharmaceuticals Ltd - Marketwire
Wed, Nov 11, 2009
6:54 AM AnalystChoice.com Provides Analytical Coverage on BMS, TKC, DTG, ACH, CTB and SLXP - Marketwire
Mon, Nov 02, 2009
5:37 AM PLAB, SLXP, ABAT, TECD, HGSI and PLUG Receiving Professional Financial Coverage from RothmanResearch.com - Marketwire
Mon, Oct 26, 2009
3:19 PM Lupin Q2 net profit rises 39% - Hindu Business Line
11:21 AM Salix Pharmaceuticals Previews American College of Gastroenterology 2009 Annual Scientific Meeting - Marketwire
Tue, Sep 15, 2009
9:38 AM Stock in Focus: Sunwin International Neutraceuticals -- September 15, 2009 - Marketwire
Tue, Aug 04, 2009
6:50 AM StockPreacher.com Issues Trading Outlook for ViroPharma Inc. - Globe Newswire
Fri, Sep 28, 2007
9:35 AM SmallCap Sentinel: Nutritional Supplement Industry Profile and Interview Made Available - Globe Newswire
More News for SLXP >>

Tags for Salix Pharmaceuticals Ltd.

Research stocks or mutual funds related to Salix Pharmaceuticals Ltd. by keywords or tags. Find companies that have a similar focus to SLXP. The keywords below have been associated to SLXP by either user submission or electronic means.

biotechnology company pharmaceuticals research pharmaceutical branding pharmaceutical industry strategy pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics biotechnology market pharmaceutical research and development pharmaceutical manufacturing company pharma marketing pharmaceutical industry marketing xifaxan pharmaceutical software pfizer pharmaceutical company pharmaceuticals supply chain pharma companies pharma consulting pharmaceutical sales pharma pharmaceutical distributors pharmaceutical development pharmaceutical sales rep pharmaceutical reports biotech Drugs veterinary pharmaceuticals pharmaceutical industry news pharmaceutical manufacturing software requip side effects pharmaceutical manufacturing contract pharmaceutical pharmaceutical consulting pharmaceutical industry pharmacy companies pharmaceutical studies pharmaceutical strategy side effects of edta pharmaceutical advances loratadine side effects pharmaceutical distributor pharmaceutical jobs pharmaceutical out licensing pharmaceutical business development trasylol side effects Gastroenterologist Healthcare bio pharmaceuticals jobs in pharmaceuticals

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.